APA

Wang X., Zhou Z., Yang M., Mai L., Zheng Z., He G., Wu Y., Lin Q., Shan Z. & Yu X. (20151026). Population pharmacokinetics and safety of eptifibatide in healthy Chinese volunteers and simulations on the dose regimens approved for a Western population. : International journal of clinical pharmacology and therapeutics.

Chicago

Wang Xi-Pei, Zhou Zhi-Ling, Yang Min, Mai Li-Ping, Zheng Zhi-Jie, He Guo-Dong, Wu Yue-Heng, Lin Qiu-Xiong, Shan Zhi-Xin and Yu Xi-Yong. 20151026. Population pharmacokinetics and safety of eptifibatide in healthy Chinese volunteers and simulations on the dose regimens approved for a Western population. : International journal of clinical pharmacology and therapeutics.

Harvard

Wang X., Zhou Z., Yang M., Mai L., Zheng Z., He G., Wu Y., Lin Q., Shan Z. and Yu X. (20151026). Population pharmacokinetics and safety of eptifibatide in healthy Chinese volunteers and simulations on the dose regimens approved for a Western population. : International journal of clinical pharmacology and therapeutics.

MLA

Wang Xi-Pei, Zhou Zhi-Ling, Yang Min, Mai Li-Ping, Zheng Zhi-Jie, He Guo-Dong, Wu Yue-Heng, Lin Qiu-Xiong, Shan Zhi-Xin and Yu Xi-Yong. Population pharmacokinetics and safety of eptifibatide in healthy Chinese volunteers and simulations on the dose regimens approved for a Western population. : International journal of clinical pharmacology and therapeutics. 20151026.